PRISMAP - The European medical isotope programme

Radziņa, Maija (Work package leader)

Department of Radiology

Description

Production of high purity isotopes by mass separation proposes to federate a consortium of the key European intense neutron sources, isotope mass separation facilities and high-power accelerators and cyclotrons, with leading biomedical research institutes and hospitals active in the translation of the emerging radionuclides into medical diagnosis and treatment

Key findings

nuclear medicine, isotope, radionuclide, radiopharmaceutical

Short title	PRISMAP
Status	Active
Effective start/end date	1/05/21 → 30/04/25
Links	https://www.prismap.eu/

Collaborative partners

Rīga Stradiņš University
University of Latvia (lead)

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

Keywords

nuclear medicine
radionuclide
radiopharmaceutical

Field of Science

1.3 Physical sciences
1.4 Chemical sciences
3.2 Clinical medicine
3.3 Health sciences
3.4 Medical biotechnology

Smart Specialization Area

Biomedicine, medical technologies and biotechnology

Access Project

PRISMAP is the European medical radionuclide programme on the production of high purity radionuclides (radioactive isotopes) by mass separation. We federate a European consortium of the key intense neutron sources, isotope mass separation facilities and high-power accelerators and cyclotrons, with leading biomedical and healthcare research institutes in the active translation of the emerging radionuclides into medical diagnosis and treatment. PRISMAP will create a single-entry point for a fragmented user community distributed amongst universities, research centres, industry and hospitals, in a similar way as how the National Isotope Development Center NIDC, supported by the Department of Energy (DOE), has provided radionuclide sources for users in the USA. PRISMAP brings together a consortium of 23 beneficiaries from 13 countries, one European Research Laboratory and an International Organisation. It receives support of leading associations and institutions in the field such as the European Association of Nuclear Medicine (EANM) and the International Atomic Energy Agency (IAEA).

1 Commissioned report

Deliverable 5.1 - Questionnaire on industrial and clinical key players and needs (v1.0).
Radzina, M. (Corresponding Author), Mamis, E., Saule, L., Pajuste, E., Kalniņa, M., Cocolios, T., Talip, Z. & Stora, T., 30 Sept 2022, 60 p.
Research output: Book/Report › Commissioned report › peer-review

Open Access
File
65 Downloads (Pure)

PRISMAP - The European medical isotope programme

Project Details

Description

Key findings

Collaborative partners

UN Sustainable Development Goals

Keywords

Field of Science

Smart Specialization Area

Access Project

Fingerprint

Deliverable 5.1 - Questionnaire on industrial and clinical key players and needs (v1.0).

PRISMAP - The European medical isotope programme

Project Details

Description

Key findings

Collaborative partners

UN Sustainable Development Goals

Keywords

Field of Science

Smart Specialization Area

Access Project

Fingerprint

Research output

Deliverable 5.1 - Questionnaire on industrial and clinical key players and needs (v1.0).